Renaissance Capital logo

Valneva Priced, Nasdaq: VALN

Commercial-stage French biotech developing vaccines for infectious diseases.

Industry: Health Care

Latest Trade: $29.46 +1.11 (+3.9%)

First Day Return: +7.3%

Return from IPO: +7.3%

Industry: Health Care

We are a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. We take a highly specialized and targeted approach to vaccine development, beginning with the identification of deadly and debilitating infectious diseases that lack a prophylactic vaccine solution and for which there are limited therapeutic treatment options. We then apply our deep understanding of vaccine science, including our expertise across multiple vaccine modalities, as well as our established vaccine development capabilities, to develop prophylactic vaccines to address these diseases. We have leveraged our expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19. We have already successfully licensed and commercialized a portfolio of traveler vaccines, which is composed of IXIARO (also marketed as JESPECT in Australia and New Zealand), indicated for the prevention of Japanese encephalitis in travelers and military personnel, and DUKORAL, indicated for the prevention of cholera and, in Canada, Switzerland, New Zealand and Thailand, prevention of diarrhea caused by enterotoxigenic Escherichia coli, or ETEC, the leading causes of travelers’ diarrhea.
more less
IPO News for Valneva
more
IPO Data
IPO File Date 04/09/2021
Offer Price $26.41
Price Range $24.04 - $28.85
Offer Shares (mm) 3.5
Deal Size ($mm) $94
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 05/05/2021
Offer Price $26.41
Price Range $24.04 - $28.85
Offer Shares (mm) 3.5
Deal Size ($mm) $94
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Saint-Herblain, France
Founded 1999
Employees 579
Website www.valneva.com